Brief: Cipher Pharmaceuticals announces Ozenoxacin accepted for review by Health Canada
12/07/2016 12:00
July 12 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals announces ozenoxacin accepted for
review by Health Canada
Source text for Eikon: ID:nCNWqNplVa
Further company coverage: CPH.TO
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million